Fraction of radiobiologically hypoxic cells in human melanoma xenografts measured by using single-cell survival, tumour growth delay and local tumour control as end points
1998

Measuring Hypoxic Cells in Melanoma Tumors

Sample size: 4 publication Evidence: moderate

Author Information

Author(s): EK Rofstad, K Miseide

Primary Institution: Institute for Cancer Research, The Norwegian Radium Hospital

Hypothesis

The study aims to establish a radiobiological basis for future non-invasive assays of tumor hypoxia using human melanoma xenograft lines.

Conclusion

The fraction of radiobiologically hypoxic cells differs significantly among the human melanoma xenograft lines, with R-18 and U-25 showing higher fractions than D-12, which in turn has a higher fraction than A-07.

Supporting Evidence

  • The hypoxic fractions were assessed using three different assays.
  • The R-18 and U-25 lines showed higher hypoxic fractions than the D-12 line.
  • The hypoxic fraction differed significantly among the lines.

Takeaway

Some parts of tumors don't get enough oxygen, which can make them harder to treat. This study looked at different types of melanoma tumors to see how many of their cells are low on oxygen.

Methodology

The study used four human melanoma xenograft lines in mice and assessed hypoxic fractions using single-cell survival, tumor growth delay, and local tumor control assays.

Limitations

The study assumes that the methods used for measuring hypoxia are valid and that the tumor models accurately represent the hypoxic conditions.

Participant Demographics

Adult female Balb/c nu/nu mice (8-12 weeks old) were used as host animals.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication